Yanwen Xu

Yanwen Xu is a highly skilled research associate scientist currently employed at Novo Nordisk since January 2025. Previously, Yanwen worked at Biocytogen from January 2022 to September 2024, where expertise in developing and executing in vitro assays, leading complex multi-color flow cytometry studies, and authoring detailed study reports was demonstrated. Earlier roles included Associate Scientist I and Senior Research Associate I, concentrating on SOP writing and managing flow cytometry operations. Yanwen began their career as an intern at Suzhou Zhonghe TopAlliance Co., Ltd, assisting in pilot-scale production for monoclonal antibody drugs. Yanwen holds a Master's degree in Biotechnology from Brandeis University and a Bachelor's degree in Bioengineering and Biomedical Engineering from Nanjing Normal University.